Karsan N, Fletcher P, Bodi I, Macdonald B K
Neurology Department, St Georges Healthcare NHS Trust, London SW17 0QT, UK.
Case Rep Neurol Med. 2012;2012:150813. doi: 10.1155/2012/150813. Epub 2012 Jun 27.
We present here a case of carcinomatous meningitis presenting as Miller Fisher syndrome (MFS). There are four further cases described in the literature with evidence of tumour invasion within the central nervous system (CNS) shown either in cerebrospinal fluid examination or on histology. There are further five cases described in which an association between cancer and a Miller Fisher phenotype has been shown. Some of these have identified antiganglioside antibodies in the serum and, in one case, also showed antibodies deposited within the primary tumour itself. This raises a question as to whether there is a paraneoplastic form. It would be informative when further cases present in this way to histologically examine for malignant CNS invasion, and the presence of antiganglioside antibodies in both the malignant primary and areas of nervous system thought to be affected by MFS.
我们在此报告一例表现为米勒-费雪综合征(MFS)的癌性脑膜炎病例。文献中还描述了另外4例病例,这些病例在脑脊液检查或组织学检查中显示有中枢神经系统(CNS)内肿瘤浸润的证据。还有5例病例被描述为癌症与米勒-费雪表型之间存在关联。其中一些病例在血清中检测到抗神经节苷脂抗体,在1例病例中,还在原发性肿瘤本身中发现了抗体沉积。这就提出了一个问题,即是否存在副肿瘤形式。当更多以这种方式出现的病例进行组织学检查以确定是否存在恶性CNS浸润,以及在恶性原发灶和被认为受MFS影响的神经系统区域中是否存在抗神经节苷脂抗体时,将会提供更多信息。